BMD Loss Slowed With Delayed Antiretroviral Therapy in HIV
Researchers examined the benefits and risks associated with delaying ART initiation to slow bone mineral density loss.
All articles by Jeff Craven
Parathyroidectomy for Secondary, Tertiary Hyperparathyroidism Increases Morbidity and Mortality
After parathyroidectomy, morbidity and mortality rates were considerably higher in patients with secondary and tertiary vs primary hyperparathyroidism.
Colecalciferol Did Not Reduce Fracture or Fall Risks
Healthy middle-age patients who took colecalciferol did not have a reduced risk for fall or fracture.
CVD Risk Management in Type 1 Diabetes Improved With Metformin
Although metformin did not improve glycemic control in patients with type 1 diabetes, the treatment did improve cardiovascular disease risk management.
Elagolix Relieves Short-Term Menstrual Pain, Dysmenorrhea in Endometriosis
Gonadotropin-releasing hormone antagonist elagolix demonstrated clinical improvement for women with endometriosis-related pain.
Liraglutide Does Not Increase Risk for Acute Pancreatitis in Type 2 Diabetes
Liraglutide does not increase the risk for acute pancreatitis in patients with type 2 diabetes who are also at high risk for cardiovascular events.
Fracture Risk Decreases, Bone Mineral Density Increases With Long-Term Denosumab
Long-term denosumab increased bone mineral density in postmenopausal women.
Insulin Sensitivity Not Affected by Vitamin D Supplementation in T2D
No between-group differences for factors such as glycemic control, endogenous glucose production, and insulin sensitivity were found.
Fast-Acting Insulin Aspart for Glycemic Control in Type 1 Diabetes
Both mealtime and postmeal faster insulin aspart are noninferior to mealtime conventional insulin aspart, regarding HbA1c change from baseline.
Increasing Bone Mineral Density in Older Men
After 1 year of therapy, men who underwent testosterone therapy experienced improvement in bone mineral density and mood.
Next post in Bone Metabolism
